Cytokinetics, Incorporated · NASDAQ:CYTK
Cytokinetics, Incorporated shareholders
As of Jun 30, 2026, 465 institutions reported holding Cytokinetics, Incorporated. Largest: T. Rowe Price, BlackRock and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Cytokinetics, Incorporated | Change | Filed |
|---|---|---|---|---|
| T. Rowe Price | 20.7M | +1.57M | Aug 14, 2026 | |
| BlackRock | 20.1M | +3.55M | Aug 7, 2026 | |
| Vanguard | 14M | +1.62M | Aug 13, 2026 | |
| Wellington | 6.93M | −1.08M | Aug 14, 2026 | |
| State Street | 6.49M | +749K | Aug 7, 2026 | |
| Fidelity | 5.03M | −5.69M | Aug 13, 2026 | |
| Avoro Capital Advisors LLC | 5M | +1.67M | Aug 14, 2026 | |
| Bank of America | 4.64M | +1.51M | Aug 14, 2026 | |
| Geode Capital | 3.71M | +497K | Aug 12, 2026 | |
| Capital Group | 3.25M | +889K | Aug 12, 2026 |